Replies to post #391772 on Elite Pharmaceuticals Inc (ELTP)

[Pharma Sleuth]

No. $1m per month is 12m per year in earnings. 10 PE is $120m cap. That is .12 PPS at 1B shares. Not complicated

And yes you can add the R&D expenses back in when you evaluate a company. Of course it is a real expense but you also need to consider if they stopped R&D and just focused on profit. The reality of what this is telling you is that you have tons of earnings being spent on the future instead of just taking profit. It would be a major part of any financial analysis. because if you don't, they you better be adding $10B dollars of their future market and the stock should be in the dollars.

You cant have it both ways although you are trying to make it sound that way. lol..wonder why

[Pharma Sleuth]

Also false. Stop Lying.

Lastly, the company is currently not profitable. It only looks that way since Nasrat is allowing them to delay the profit splits. These profit split amounts are in excess of the stated earnings amount. Fun fact, at the current revenue rate, Nasrat is making over 7 million a year in profit just from Adderall ir and er profit splits. Elite would need well over 20 million $ to purchase it from him. Nasrat could retire today and make 7 million a year in annuities from this.

The cost is already in there. The profit is correct. They deferred the cash payment so they can use the cash to buy API. Massive amounts. (My speculation with Adderall ER launching in a few weeks)

[jour_trader]

I disagree with your profit split accounting and overall profitability comments. The income statement includes the profit split in the period it’s incurred as an expense. What doesn’t get paid out simply sits on balance sheet as a liability. The current accounting is correct.